In a melanoma mouse model, feeding mice Bifidobacterium improved tumor control to the same degree as anti-PD-L1 therapy, and combining Bifidobacterium with anti-PD-L1 nearly eradicated the tumors​ [174]. The gene discussed is CD274; the disease is melanoma.